Canntab Therapeutics Limited Stock price Deutsche Boerse AG
Equities
TBF1
CA1377991023
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0005 EUR | -.--% | -.--% | -.--% |
Sales 2021 | - | Sales 2022 | 0.29 0.27 | Capitalization | 11.48M 10.64M |
---|---|---|---|---|---|
Net income 2021 | -4M -3.71M | Net income 2022 | -3M -2.78M | EV / Sales 2021 | - |
Net Debt 2021 | 75.05K 69.57K | Net Debt 2022 | 1.15M 1.07M | EV / Sales 2022 | 43,043,762 x |
P/E ratio 2021 |
-7.9
x | P/E ratio 2022 |
-3.02
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 86.26% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 16-04-19 | |
President | 56 | 16-04-19 | |
Chief Tech/Sci/R&D Officer | - | 20-05-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
President | 56 | 16-04-19 | |
Barry Polisuk
BRD | Director/Board Member | 61 | 18-04-10 |
Vitor Fonseca
BRD | Director/Board Member | 71 | 18-04-10 |
1st Jan change | Capi. | |
---|---|---|
+23.32% | 5.39B | |
-12.48% | 4.67B | |
-6.70% | 3.29B | |
-16.43% | 2.6B | |
-2.41% | 2.52B | |
-7.97% | 1.7B | |
+24.37% | 1.63B | |
-8.02% | 1.61B | |
-4.40% | 1.56B |
- Stock
- Equities
- Stock Canntab Therapeutics Limited
- Stock Canntab Therapeutics Limited - Deutsche Boerse AG